Metraipolis › archive › dc_44a1401de282

Biologic therapies for severe pediatric asthma: efficacy, safety, and biomarker-guided selection — Europe PMC PMID:41640839

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41640839
DOI
10.3389/falgy.2026.1757445
License (as archived)
solo-consultazione
Archived
2026-11-06T16:48:40.982Z
SHA-256 of the archived text
6279ec343bd353aed67cc5769deb1877134eb1f5f6f82904c7d2e9241f51529b
Stable URL of this page
https://metraipolis.com/documento/dc_44a1401de282

How to cite

Biologic therapies for severe pediatric asthma: efficacy, safety, and biomarker-guided selection — Europe PMC PMID:41640839 — Europe PMC (en), https://europepmc.org/article/MED/41640839 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_44a1401de282 (Metraipolis archive dc_44a1401de282, sha256 6279ec343bd353aed67cc5769deb1877134eb1f5f6f82904c7d2e9241f51529b)
BibTeX
@misc{dc44a1401de282,
  title = {Biologic therapies for severe pediatric asthma: efficacy, safety, and biomarker-guided selection — Europe PMC PMID:41640839},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41640839},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_44a1401de282; sha256 6279ec343bd353aed67cc5769deb1877134eb1f5f6f82904c7d2e9241f51529b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41640839. Agents can read the archived copy with the MCP tool read_document.